Color Health IPO
Color Health is a healthcare technology company that provides population health services, including genetic testing, COVID-19 testing, and health screening programs. The company partners with employers, health plans, and government agencies to deliver scalable health programs and has gained prominence for its role in COVID-19 testing infrastructure. Investors have shown interest in the company's technology-driven approach to population health management.
Key Facts
| Industry | Biotechnology |
| Founded | 2013 |
| Headquarters | Burlingame, CA |
| Employees | ~400 |
| Website | color.com |
| Funding | Series D at $4.6B valuation. Total raised: ~$278M |
About Color Health
Color Health (formerly Color Genomics) is a population health technology company that provides genetic testing and screening services primarily focused on hereditary cancer and cardiac conditions. The company offers comprehensive genetic testing panels that help identify individuals at risk for conditions like BRCA-related cancers, Lynch syndrome, and familial hypercholesterolemia. Color has built a platform that combines genetic testing with clinical-grade interpretation and genetic counseling services.
The company has differentiated itself by focusing on making genetic testing accessible at scale through partnerships with health systems, employers, and life insurers. Color's approach emphasizes population-level screening rather than individual consumer testing, working with organizations like the Department of Veterans Affairs and various health plans to implement large-scale genetic screening programs. Their technology platform integrates genetic testing with clinical workflows and provides actionable insights for both patients and healthcare providers.
IPO Status
Color Health has raised significant funding over multiple rounds, with reports of valuations reaching into the billions during the height of the COVID-19 pandemic when demand for testing services was high. The company expanded rapidly during the pandemic, providing testing services to major organizations and government entities. However, as pandemic-related testing demand has normalized, the company has been focusing on its broader population health platform. While Color Health's growth and market position could make it a candidate for an IPO, no official plans have been announced. The company continues to operate as a private entity while expanding its healthcare services beyond COVID-19 testing to include other population health initiatives.
Competitors
Frequently Asked Questions
Does Color Health have a stock?
No, Color Health has not had an IPO and remains a private company. The company has raised private funding but has not announced any plans to go public.
When is the Color Health IPO date?
There is no confirmed IPO date for Color Health, as the company has not announced any plans to go public. Any timeline for a potential IPO remains speculative.
How can I buy Color Health stock?
You cannot buy Color Health stock as it is currently a private company. The stock is not available on public exchanges and is only accessible to qualified private investors.
Stay Updated on the Color Health IPO
Get real-time alerts when Color Health files for an IPO, prices shares, or begins trading.
Get IPO Alerts